Skip main navigation

RNA/DNA Vaccines

This article explores the advantages and limitations of RNA/DNA Vaccines.
© BSAC

RNA and DNA are types of genetic material that encode specific proteins.

Specific SARS-CoV-2 proteins, for example the spike proteins which mediate viral entry into cells, can be used as vaccine antigens. On vaccination with RNA or DNA, this genetic material enters human cells and uses the cell’s machinery to produce the protein they encode. The immune system then recognises this protein and produces an immune response which may be able to protect against subsequent natural infection. The image below explains this process.

infographic showing how a RNA vaccine works - 1. RNA injected into body, 2. RNA encodes information to produce the antigen that stimulates the immune system, 3. RNA enters human cells and uses cell's machinery to produce the protein they need, 4. RNA synthesises the antigen, which is exposed to the cell surface, 5. The immune system recognises the antigen and triggers an immune response, which could protect against future infection.

If you need a text version of the above image, this is available as a PDF.

In the video below Professor Robin Shattock gives an overview of the COVID-19 RNA vaccine developed at Imperial College London.

This is an additional video, hosted on YouTube.

A PDF summary of the video can be found in the downloads section below.

RNA and DNA vaccines are a relatively new type of vaccine and no vaccines of this are currently licensed.

Advantages Limitations
Do not involve any infectious agents so are suitable for most people The immune response generated may not be as potent as that induced with vaccines that contain complete SARS-CoV-2 virus
Can be manufactured more quickly and for less cost than egg-based vaccines Multiple doses may be required
Potential to be given by different routes so could be needle-free  
Low cost  
Antigen sparing (only small amounts of material needed so there is potential to make more vaccines  

RNA/DNA vaccines have many advantages, and due to their novelty we are still learning more about them all the time. The next step will look at viral vectored vaccines, which utilise genetic material from the infectious agent.

© BSAC
This article is from the free online

Vaccine Development: Finding a Vaccine for COVID-19 and Future Pandemics

Created by
FutureLearn - Learning For Life

Our purpose is to transform access to education.

We offer a diverse selection of courses from leading universities and cultural institutions from around the world. These are delivered one step at a time, and are accessible on mobile, tablet and desktop, so you can fit learning around your life.

We believe learning should be an enjoyable, social experience, so our courses offer the opportunity to discuss what you’re learning with others as you go, helping you make fresh discoveries and form new ideas.
You can unlock new opportunities with unlimited access to hundreds of online short courses for a year by subscribing to our Unlimited package. Build your knowledge with top universities and organisations.

Learn more about how FutureLearn is transforming access to education